Immunovant's stock fell despite positive batoclimab study results. The company focuses on IMVT-1402 for autoimmune conditions, deferring regulatory decisions.
Immunovant's stock fell despite positive batoclimab study results. The company focuses on IMVT-1402 for autoimmune conditions, deferring regulatory decisions.
Analysis of market drivers: Fed meeting, Turkish unrest after Istanbul mayor arrest, Ukraine energy ceasefire impacts oil markets. See key economic trends.
Analysis of market drivers: Fed meeting, Turkish unrest after Istanbul mayor arrest, Ukraine energy ceasefire impacts oil markets. See key economic trends.
US Industrial Production exceeds forecasts, rising 0.7% and boosting the USD outlook, reflecting strong industrial sector growth and economic momentum.
US Industrial Production exceeds forecasts, rising 0.7% and boosting the USD outlook, reflecting strong industrial sector growth and economic momentum.
Close Brothers shares plunge 18% amid motor finance provisions, squeezed margins. Learn about the key factors impacting the stock and the analyst's outlook.
Close Brothers shares plunge 18% amid motor finance provisions, squeezed margins. Learn about the key factors impacting the stock and the analyst's outlook.
Close Brothers shares plunge 18% amid motor finance provisions, squeezed margins. Learn about the key factors impacting the stock and the analyst's outlook.